Dongguan, China

Dongming Li

This inventor holds 1 USPTO granted patent. Top assignee: Sunshine Lake Pharma Co., Ltd.. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dongming Li. Retrieved from https://idiyas.com/inventor/dongming-li-m40cyqw0

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Dongming Li

Introduction

Dongming Li is a notable inventor based in Dongguan, China. He has made significant contributions to the field of chemistry, particularly in the development of novel compounds. His work has led to the creation of a unique diaryl thioether piperazine compound, which has various applications in the pharmaceutical industry.

Latest Patents

Dongming Li holds a patent for "Diaryl thioether piperazine compounds, preparation methods and uses thereof." This invention relates to a diaryl thioether piperazine compound, specifically a compound of Formula (I), wherein HX is a fatty acid or pamoic acid. This innovative compound showcases his expertise in chemical synthesis and its potential uses in medicinal applications.

Career Highlights

Li is currently employed at Sunshine Lake Pharma Co., Ltd., where he continues to advance his research and development efforts. His work at this company has allowed him to collaborate with other talented professionals in the field, further enhancing his contributions to pharmaceutical innovations.

Collaborations

Some of his notable coworkers include Xin Lei and Zhonghua Luo. Their collaborative efforts have likely played a role in the successful development of new compounds and research initiatives within the company.

Conclusion

Dongming Li's innovative work in the field of chemistry, particularly with his patented diaryl thioether piperazine compounds, highlights his significant contributions to the pharmaceutical industry. His ongoing research and collaborations promise to lead to further advancements in this vital area of science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…